TY - JOUR
T1 - Dynamics of necroptosis in kidney ischemia-reperfusion injury
AU - Pefanis, Aspasia
AU - Bongoni, Anjan K.
AU - McRae, Jennifer L.
AU - Salvaris, Evelyn J.
AU - Fisicaro, Nella
AU - Murphy, James M.
AU - Ierino, Francesco L.
AU - Cowan, Peter J.
N1 - Funding Information:
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was funded in part by grant number 88279 from the St Vincent’s Hospital Melbourne Research Endowment Fund. AP was supported by a postgraduate scholarship and JMM by an Investigator Grant (1172929) from the National Health & Medical Research Council (NHMRC) of Australia. JMM acknowledges infrastructure support from the NHMRC (IRIISS 9000719) and the Victorian State Government Operational Infrastructure Support Scheme. Acknowledgments
Funding Information:
Authors JMM and PC have received research funding from Anaxis Pharma Pty Ltd.
Publisher Copyright:
Copyright © 2023 Pefanis, Bongoni, McRae, Salvaris, Fisicaro, Murphy, Ierino and Cowan.
PY - 2023
Y1 - 2023
N2 - Necroptosis, a pathway of regulated necrosis, involves recruitment and activation of RIPK1, RIPK3 and MLKL, leading to cell membrane rupture, cell death and release of intracellular contents causing further injury and inflammation. Necroptosis is believed to play an important role in the pathogenesis of kidney ischemia-reperfusion injury (IRI). However, the dynamics of necroptosis in kidney IRI is poorly understood, in part due to difficulties in detecting phosphorylated MLKL (pMLKL), the executioner of the necroptosis pathway. Here, we investigated the temporal and spatial activation of necroptosis in a mouse model of unilateral warm kidney IRI, using a robust method to stain pMLKL. We identified the period 3-12 hrs after reperfusion as a critical phase for the activation of necroptosis in proximal tubular cells. After 12 hrs, the predominant pattern of pMLKL staining shifted from cytoplasmic to membrane, indicating progression to the terminal phase of necroptotic cell death. Mlkl-ko mice exhibited reduced kidney inflammation at 12 hrs and lower serum creatinine and tubular injury at 24 hrs compared to wild-type littermates. Interestingly, we observed increased apoptosis in the injured kidneys of Mlkl-ko mice, suggesting a relationship between necroptosis and apoptosis in kidney IRI. Together, our findings confirm the role of necroptosis and necroinflammation in kidney IRI, and identify the first 3 hrs following reperfusion as a potential window for targeted treatments.
AB - Necroptosis, a pathway of regulated necrosis, involves recruitment and activation of RIPK1, RIPK3 and MLKL, leading to cell membrane rupture, cell death and release of intracellular contents causing further injury and inflammation. Necroptosis is believed to play an important role in the pathogenesis of kidney ischemia-reperfusion injury (IRI). However, the dynamics of necroptosis in kidney IRI is poorly understood, in part due to difficulties in detecting phosphorylated MLKL (pMLKL), the executioner of the necroptosis pathway. Here, we investigated the temporal and spatial activation of necroptosis in a mouse model of unilateral warm kidney IRI, using a robust method to stain pMLKL. We identified the period 3-12 hrs after reperfusion as a critical phase for the activation of necroptosis in proximal tubular cells. After 12 hrs, the predominant pattern of pMLKL staining shifted from cytoplasmic to membrane, indicating progression to the terminal phase of necroptotic cell death. Mlkl-ko mice exhibited reduced kidney inflammation at 12 hrs and lower serum creatinine and tubular injury at 24 hrs compared to wild-type littermates. Interestingly, we observed increased apoptosis in the injured kidneys of Mlkl-ko mice, suggesting a relationship between necroptosis and apoptosis in kidney IRI. Together, our findings confirm the role of necroptosis and necroinflammation in kidney IRI, and identify the first 3 hrs following reperfusion as a potential window for targeted treatments.
KW - acute kidney injury
KW - chronic kidney disease
KW - ischemia-reperfusion
KW - mlkl
KW - necroinflammation
KW - necroptosis
UR - https://www.scopus.com/pages/publications/85177038898
U2 - 10.3389/fimmu.2023.1251452
DO - 10.3389/fimmu.2023.1251452
M3 - Article
C2 - 38022500
AN - SCOPUS:85177038898
SN - 1664-3224
VL - 14
JO - Frontiers in Immunology
JF - Frontiers in Immunology
M1 - 1251452
ER -